Web Analytics

3 Latest Announced Rounds

  • $38,000,000
    Series C

    1 Investors

    Financial Services
    Aug 5th, 2025
  • $8,000,000
    Unknown
    Pharmaceutical Manufacturing
    Aug 5th, 2025
  • $2,600,000
    Pre-Seed

    2 Investors

    Software Development
    Aug 5th, 2025
$1,267.05M Raised in 58 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Sigrid Therapeutics AB

start up
Sweden - Stockholm
  • 20/01/2023
  • Unknown
  • $580,679

Lifestyle diseases, caused by poor diet and physical inactivity among others, are rising worldwide. Each year 70% of all deaths globally – 40 million – are attributed to lifestyle diseases such as obesity, type 2 diabetes and heart disease.

Sigrid is a clinical-stage biotech company driven by the vision to improve human health through material-based innovations. We are pioneering a new class of engineered materials to prevent and treat lifestyle disease more safely and effectively.


Related People

Sana AlajmovicCo Founder

Sana Alajmovic Sweden - Greater Stockholm Metropolitan Area

Entrepreneur with a demonstrated history of working in the biotechnology industry. Skilled in Business Planning, Operations Management, Sales, Entrepreneurship, and International Business. Strong business development professional with a BSc Program in Business and Economcis focused in Economics and Marketing from Stockholm School of Economics.